Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Automated Gene Expression-Based Platform for Multidimensional Assessment and Interpretation of Kidney Allograft Biopsies: Development and Multicenter External Validation (HistoMX)

NCT07700563 is registered in ClinicalTrials.gov with Paris Translational Research Center for Organ Transplantation as lead sponsor.

NCT NCT07700563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07700563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Automated Gene Expression-Based Platform for Multidimensional Assessment and Interpretation of Kidney Allograft Biopsies: Development and Multicenter External Validation (HistoMX)
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Phase
Observational
Overall status
Completed
Start date
January 1, 2004
Completion date
May 15, 2026
Enrollment
2,410 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibody mediated rejection, bk virus nephropathy, chronic kidney disease (ckd) stage 5, kidney allograft injury, kidney transplant, rejection of renal transplant, t-cell mediated rejection